NASDAQ: AVGR - Avinger, Inc.

Rentabilidad a seis meses: -51.63%
Rendimiento de dividendos: 0.00%
Sector: Healthcare

Calendario de promoción Avinger, Inc.


Acerca de la empresa Avinger, Inc.

Avinger, Inc., a commercial-stage medical device company, designs, manufactures, and sells a suite of image-guided and catheter-based systems used by physicians to treat patients with peripheral artery disease (PAD) in the United States and internationally. It develops lumivascular platform that integrates optical coherence tomography visualization with interventional catheters to provide real-time intravascular imaging during the treatment portion of PAD procedures.

más detalles
The company's lumivascular products comprise Lightbox imaging consoles, as well as the Ocelot family of catheters, including Ocelot and Tigereye, which are designed to allow physicians to penetrate a total blockage in an artery; and Pantheris, an image-guided atherectomy device that allows physicians to precisely remove arterial plaque in PAD patients. In addition, its chronic total occlusion (CTO)-crossing catheters, Wildcat and Kittycat 2, which employs a proprietary design that uses a rotational spinning technique allowing the physician to switch between passive and active modes when navigating across a CTO. Further, the company develops IMAGE-BTK for the treatment of PAD lesions below-the-knee. It markets and sells its products to interventional cardiologists, vascular surgeons, and interventional radiologists. The company was incorporated in 2007 and is headquartered in Redwood City, California.

IPO date 2015-01-30
ISIN US0537348858
Industry Health Care Equipment & Supplies
Sector Health Care
Валюта usd
Валюта отчета usd
Сайт https://avinger.com
Цена ао 0.474
Cambio de precio por día: 0% (0.474)
Cambio de precio por semana.: 0% (0.474)
Cambio de precio por mes: -12.16% (0.5396)
Cambio de precio en 3 meses.: -43.57% (0.84)
Cambio de precio en seis meses: -51.63% (0.98)
Cambio de precio por año: -87.36% (3.7497)
Cambio de precio en 3 años.: +106.09% (0.23)
Cambio de precio en 5 años.: -22.79% (0.6139)
Cambio de precio en 10 años.: 0% (0.474)
Cambio de precio desde principios de año.: -1.78% (0.4826)

Subestimación

Nombre Significado Calificación
P/S 0.2825 10
P/BV -0.3485 0
P/E 0 0
EV/EBITDA -0.8056 0
Total: 5

Eficiencia

Nombre Significado Calificación
ROA, % -133.04 0
ROE, % 295.39 10
Total: 3.33

Dividendos

Nombre Significado Calificación
Div yield, % 0 0
DSI 0 0
Total: 0

Deber

Nombre Significado Calificación
Debt/EBITDA -1.01 10
Total: 9.6

Impulso de crecimiento

Nombre Significado Calificación
Rentabilidad Revenue, % -15.91 0
Rentabilidad Ebitda, % -15.74 0
Rentabilidad EPS, % -57.29 0
Total: 0



Supervisor Título profesional Pago año de nacimiento
Mr. Jeffrey M. Soinski CEO & Director 616.79k 1962 (63 año)
Mr. Nabeel P. Subainati Vice President of Finance 347.58k 1984 (41 año)
Mr. Himanshu N. Patel Chief Technology Officer 430.08k 1960 (65 años)
Mr. Keith Schaefer Chief Operating Officer N/A
Mr. Corey Gibbs Vice President of Sales N/A
Dr. Jaafer Golzar FACC, M.D. Chief Medical Officer N/A
Mr. Philip R. Preuss Chief Marketing Officer & VP of Business Operations N/A 1978 (47 años)

DIRECCIÓN: United States, Redwood City. CA, 400 Chesapeake Drive - abrir en mapas de google, abrir mapas de Yandex
Sitio web: https://avinger.com